Henderson Janeinsider trades
In SEC Form 4 filings, Henderson Jane is listed as Chief Financial Officer of Apogee Therapeutics, Inc. (APGE). Henderson Jane reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 3.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| APGEApogee Therapeutics, Inc. | Chief Financial Officer | 4 | Sep 3 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| APGEApogee Therapeutics, Inc. | Sep 3 | Sep 3 | D | 158,371 | not reported | not reported | not reported | No | Form 4 |
| APGEApogee Therapeutics, Inc. | Sep 3 | Sep 3 | D · derivative | 175,345 | $22.86 | $4,008,387 | not reported | No | Form 4 |
| APGEApogee Therapeutics, Inc. | Sep 3 | Sep 3 | D · derivative | 124,962 | $49.07 | $6,131,885 | not reported | No | Form 4 |
| APGEApogee Therapeutics, Inc. | Sep 3 | Sep 3 | D · derivative | 83,690 | $75.78 | $6,342,028 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.